Search - tctmd.com

Displaying 121 - 140 of 188

Sort: Relevancy | Date

News Conference News VIVA 2017

Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients

L.A. McKeown

September 11, 2017

News Daily News

Betrixaban Approved for Prevention of VTE

Michael O'Riordan

June 23, 2017

News Daily News

Inferior Vena Cava Filters: The Longer They’re In, the Higher the Risk of Adverse Events

L.A. McKeown

June 19, 2017

News Daily News

Apixaban Recalled Following Complaints of Dose-Packaging Mismatch

Shelley Wood

June 13, 2017

News Daily News

Registry Study Makes Case Against Vena Cava Filter Use in Trauma Patients, but Experts Say Not So Fast

Yael L. Maxwell

May 10, 2017

News Conference News ACC 2017

Rivaroxaban Bests Aspirin for Preventing Recurrence of VTE: EINSTEIN CHOICE

L.A. McKeown

March 18, 2017

News Conference News ISET 2017

Percutaneous Bypass for Long, Complex SFA Lesions Holds Up Well to 6 Months: DETOUR I Study

Caitlin E. Cox

February 10, 2017

News Daily News

Rivaroxaban’s ‘Overwhelming’ Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS

Todd Neale

February 08, 2017

Presentation ISET 2017

Who Should Undergo Deep Vein thrombosis Lysis? A Review of The Trial Data

Presenter: William T. Kuo

February 04, 2017

News Daily News

Questions Over Risk-Benefit Balance for IVC Filters Still Vex Clinicians

Caitlin E. Cox

November 17, 2016

News Conference News ESC 2016

Simplified VTE Protocol Rules Out Pulmonary Embolism, Reduces Use of CT Imaging: YEARS Study

Michael O'Riordan

September 02, 2016

News Daily News

Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI

Michael O'Riordan

August 24, 2016

News Opinion Editor's Corner

ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness

Shelley Wood

August 24, 2016

News Industry News

VENITI® Completes First Use Of VICI VERTO VENOUS STENT™, Novel Venous Stent System

April 22, 2016

News Daily News

Vena Cava Filters Appear to Benefit Only a Small Fraction of Patients With Acute VTE

Todd Neale

April 12, 2016

News Daily News

Even Without Proof of Benefit, 1 in 6 Patients Still Given Vena Caval Filters

Yael L. Maxwell

February 29, 2016

News Industry News

Real-World Data Confirms Safety and Efficacy Profile of XARELTO®, With Shorter Hospital Stays, for the Treatment of Deep Vein Thrombosis

December 07, 2015

News Industry News

Boston Scientific Receives FDA Approval And CE Mark For AngioJet™ ZelanteDVT™ Thrombectomy Catheter

November 30, 2015

News Daily News

Patients With Acute Pulmonary Embolism Fare Better With More-Targeted Thrombolysis

Todd Neale

September 10, 2015

News Industry News

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

July 13, 2015

Advertisement

Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients

Betrixaban Approved for Prevention of VTE

Inferior Vena Cava Filters: The Longer They’re In, the Higher the Risk of Adverse Events

Apixaban Recalled Following Complaints of Dose-Packaging Mismatch

Registry Study Makes Case Against Vena Cava Filter Use in Trauma Patients, but Experts Say Not So Fast

Rivaroxaban Bests Aspirin for Preventing Recurrence of VTE: EINSTEIN CHOICE

Percutaneous Bypass for Long, Complex SFA Lesions Holds Up Well to 6 Months: DETOUR I Study

Rivaroxaban’s ‘Overwhelming’ Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS

Who Should Undergo Deep Vein thrombosis Lysis? A Review of The Trial Data

Questions Over Risk-Benefit Balance for IVC Filters Still Vex Clinicians

Simplified VTE Protocol Rules Out Pulmonary Embolism, Reduces Use of CT Imaging: YEARS Study

Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI

ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness

VENITI® Completes First Use Of VICI VERTO VENOUS STENT™, Novel Venous Stent System

Vena Cava Filters Appear to Benefit Only a Small Fraction of Patients With Acute VTE

Even Without Proof of Benefit, 1 in 6 Patients Still Given Vena Caval Filters

Real-World Data Confirms Safety and Efficacy Profile of XARELTO®, With Shorter Hospital Stays, for the Treatment of Deep Vein Thrombosis

Boston Scientific Receives FDA Approval And CE Mark For AngioJet™ ZelanteDVT™ Thrombectomy Catheter

Patients With Acute Pulmonary Embolism Fare Better With More-Targeted Thrombolysis

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content